SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001372514-23-000105
Filing Date
2023-07-11
Accepted
2023-07-11 17:00:20
Documents
8
Period of Report
2023-08-31

Document Format Files

Seq Description Document Type Size
1 PRE 14A kiora-preliminaryproxyxspe.htm PRE 14A 608528
2 GRAPHIC chart-e1794aad13154bc8b36.jpg GRAPHIC 72353
3 GRAPHIC image_1a.jpg GRAPHIC 115
4 GRAPHIC image_27a.jpg GRAPHIC 115
5 KIORA LOGO kioralogo.jpg GRAPHIC 36955
6 KIORA LOGO logo.jpg GRAPHIC 20251
7 PROXYCARD2 proxycard_prelim-pg2.jpg GRAPHIC 83007
8 PROXYCARD1 proxycard_prelim.jpg GRAPHIC 97090
  Complete submission text file 0001372514-23-000105.txt   1037422
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36672 | Film No.: 231082667
SIC: 2834 Pharmaceutical Preparations